Barclays »

Caris Life Sciences shares owned by Barclays

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $96k 3.2k 30.25
2025-06-30 $267k 10k 26.70

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences